Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
| Published in: | Rare Cancers and Therapy |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867301675770839043 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Rare Cancers and Therapy |
| description | |
| discipline_display | Oncology |
| discipline_facet | Oncology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:61394 |
| institution | FRELIP |
| journal_source_facet | Rare Cancers and Therapy |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Results from a Pilot Study of HyBryte™ (Topical Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL Oncology General Oncology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Oncology General Oncology Oncology General Oncology |
| subject_facet | Oncology General Oncology |
| title | Results from a Pilot Study of HyBryte™ (Topical Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL |
| title_auth | Results from a Pilot Study of HyBryte™ (Topical Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL |
| title_full | Results from a Pilot Study of HyBryte™ (Topical Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL |
| title_fullStr | Results from a Pilot Study of HyBryte™ (Topical Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL |
| title_full_unstemmed | Results from a Pilot Study of HyBryte™ (Topical Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL |
| title_short | Results from a Pilot Study of HyBryte™ (Topical Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL |
| title_sort | results from a pilot study of hybryte™ (topical synthetic hypericin) versus valchlor (mechlorethamine) in the treatment of ctcl |
| topic | Oncology General Oncology |
| url | https://link.springer.com/article/10.1007/s40487-026-00430-1 |